125 related articles for article (PubMed ID: 6131829)
1. Evidence that nalorphine, butorphanol and oxilorphan are partial agonists at a kappa-opioid receptor.
Leander JD
Eur J Pharmacol; 1983 Jan; 86(3-4):467-70. PubMed ID: 6131829
[TBL] [Abstract][Full Text] [Related]
2. Butorphanol, levallorphan, nalbuphine and nalorphine as antagonists in the squirrel monkey.
Dykstra LA
J Pharmacol Exp Ther; 1990 Jul; 254(1):245-52. PubMed ID: 2164093
[TBL] [Abstract][Full Text] [Related]
3. Discriminative stimulus effects of mu and kappa opioids in the pigeon: analysis of the effects of full and partial mu and kappa agonists.
Picker MJ; Dykstra LA
J Pharmacol Exp Ther; 1989 May; 249(2):557-66. PubMed ID: 2566680
[TBL] [Abstract][Full Text] [Related]
4. Kappa agonist-induced diuresis: evidence for stereoselectivity, strain differences, independence of hydration variables and a result of decreased plasma vasopressin levels.
Leander JD; Hart JC; Zerbe RL
J Pharmacol Exp Ther; 1987 Jul; 242(1):33-9. PubMed ID: 3039112
[TBL] [Abstract][Full Text] [Related]
5. Butorphanol's efficacy at mu and kappa opioid receptors: inferences based on the schedule-controlled behavior of nontolerant and morphine-tolerant rats and on the responding of rats under a drug discrimination procedure.
Picker MJ; Negus SS; Craft RM
Pharmacol Biochem Behav; 1990 Jul; 36(3):563-8. PubMed ID: 2165617
[TBL] [Abstract][Full Text] [Related]
6. A kappa opioid effect: increased urination in the rat.
Leander JD
J Pharmacol Exp Ther; 1983 Jan; 224(1):89-94. PubMed ID: 6294284
[TBL] [Abstract][Full Text] [Related]
7. Further study of kappa opioids on increased urination.
Leander JD
J Pharmacol Exp Ther; 1983 Oct; 227(1):35-41. PubMed ID: 6137557
[TBL] [Abstract][Full Text] [Related]
8. Opiate receptor pharmacology: mixed agonist/antagonist narcotics.
Hameroff SR
Contemp Anesth Pract; 1983; 7():27-43. PubMed ID: 6136392
[No Abstract] [Full Text] [Related]
9. Discriminative stimulus effects of butorphanol: influence of training dose on the substitution patterns produced by Mu, Kappa and Delta opioid agonists.
Picker MJ; Benyas S; Horwitz JA; Thompson K; Mathewson C; Smith MA
J Pharmacol Exp Ther; 1996 Dec; 279(3):1130-41. PubMed ID: 8968334
[TBL] [Abstract][Full Text] [Related]
10. Profile of activity of kappa receptor agonists in the rabbit vas deferens.
Hayes A; Kelly A
Eur J Pharmacol; 1985 Apr; 110(3):317-22. PubMed ID: 2988982
[TBL] [Abstract][Full Text] [Related]
11. Discriminative stimulus effects of opioids in pigeons trained to discriminate fentanyl, bremazocine and water: evidence of pharmacological selectivity.
Picker MJ; Cook CD
Behav Pharmacol; 1997 Jun; 8(2-3):160-73. PubMed ID: 9833011
[TBL] [Abstract][Full Text] [Related]
12. Acute and chronic morphine administration: effects of mixed-action opioids in rats and squirrel monkeys responding under a schedule of food presentation.
Oliveto AH; Picker MJ; Dykstra LA
J Pharmacol Exp Ther; 1991 Apr; 257(1):8-18. PubMed ID: 1850479
[TBL] [Abstract][Full Text] [Related]
13. The kappa-opioid antagonist GNTI reduces U50,488-, DAMGO-, and deprivation-induced feeding, but not butorphanol- and neuropeptide Y-induced feeding in rats.
Jewett DC; Grace MK; Jones RM; Billington CJ; Portoghese PS; Levine AS
Brain Res; 2001 Aug; 909(1-2):75-80. PubMed ID: 11478923
[TBL] [Abstract][Full Text] [Related]
14. Diuretic effect of bremazocine, a kappa-opioid with central and peripheral sites of action.
Salas SP; Roblero J; Ureta H; Huidobro-Toro JP
J Pharmacol Exp Ther; 1989 Sep; 250(3):992-9. PubMed ID: 2550625
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the opioid activity of CAM and kappa agonists.
Furst S; Friedmann T; Kovacs A; Wagner T
NIDA Res Monogr; 1986; 75():224-7. PubMed ID: 2828975
[TBL] [Abstract][Full Text] [Related]
16. Evidence for a role of opioid peptides in the release of arginine vasopressin in the conscious rat.
Ishikawa S; Schrier RW
J Clin Invest; 1982 Mar; 69(3):666-72. PubMed ID: 6174549
[TBL] [Abstract][Full Text] [Related]
17. Butorphanol and nalbuphine: a pharmacologic comparison.
Pallasch TJ; Gill CJ
Oral Surg Oral Med Oral Pathol; 1985 Jan; 59(1):15-20. PubMed ID: 2983281
[TBL] [Abstract][Full Text] [Related]
18. Clinical pharmacology of antagonists of narcotic-induced respiratory depression. A brief review.
Bowdle TA
Acute Care; 1988; 12 Suppl 1():70-6. PubMed ID: 3278495
[TBL] [Abstract][Full Text] [Related]
19. Partial agonist properties and toxicity of oral oxilorphan.
Sellers EM; Thakur R
J Clin Pharmacol; 1976 Apr; 16(4):183-7. PubMed ID: 4472
[TBL] [Abstract][Full Text] [Related]
20. Butorphanol in perspective.
Rosow CE
Acute Care; 1988; 12 Suppl 1():2-7. PubMed ID: 2830756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
